Aus Bio Ltd. Researcher Wen-YangÌýWu
Wen-Yang Wu, executive director of research and development at Aus Bio Ltd., poses for a photograph at the company's laboratory in Melbourne, Australia, on Tuesday, Feb. 6, 2018. Wu, who helped discover GlaxoSmithKline Plc's flu drug Relenza, is developing a novel way of preventing flu viruses from infecting respiratory cells. It works by reshaping the hemagglutinin, another protein on the surface of the virus, by creating a low pH environment that mimics the change that occurs after a virus invades a host cell, Wu said. Photographer: Carla Gottgens/Bloomberg via Getty Images
PURCHASE A LICENSE
How can I use this image?
€300.00
EUR
Getty ImagesAus Bio Ltd. Researcher Wen-YangÌýWu, News Photo
Aus Bio Ltd. Researcher Wen-YangÌýWu Get premium, high resolution news photos at Getty ImagesProduct #:916059326
Aus Bio Ltd. Researcher Wen-YangÌýWu Get premium, high resolution news photos at Getty ImagesProduct #:916059326€475€115
Getty Images
In stockDETAILS
Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Editorial #:
916059326
Collection:
Bloomberg
Date created:
February 06, 2018
Upload date:
License type:
Release info:
Not released.ÌýMore information
Source:
Bloomberg
Object name:
AUSTRALIA AUSBIO
Max file size:
4000 x 2662 px (13.33 x 8.87 in) - 300 dpi - 3 MB